150 related articles for article (PubMed ID: 17467629)
1. Genetic modulation of cardiac repolarization reserve.
Remme CA; Bezzina CR
Heart Rhythm; 2007 May; 4(5):608-10. PubMed ID: 17467629
[No Abstract] [Full Text] [Related]
2. Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes.
Lehtonen A; Fodstad H; Laitinen-Forsblom P; Toivonen L; Kontula K; Swan H
Heart Rhythm; 2007 May; 4(5):603-7. PubMed ID: 17467628
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of ventricular pacing in the treatment of an arrhythmic storm associated with a congenital long QT mutation.
Aziz PF; Shah MJ
Congenit Heart Dis; 2013; 8(6):E165-7. PubMed ID: 23075154
[TBL] [Abstract][Full Text] [Related]
4. Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management.
Anderson ME; Al-Khatib SM; Roden DM; Califf RM;
Am Heart J; 2002 Nov; 144(5):769-81. PubMed ID: 12422144
[No Abstract] [Full Text] [Related]
5. Gene mutations associated with atrioventricular block complicated by long QT syndrome.
Nishizaki M; Hiraoka M
Circ J; 2010 Nov; 74(12):2546-7. PubMed ID: 21088333
[No Abstract] [Full Text] [Related]
6. Drug-induced long QT syndrome: a continuing challenge in the field.
Glatter KA; Hamdan MH; Zhang Q; Chiamvimonvat N
J Cardiovasc Electrophysiol; 2007 Jul; 18(7):696-7. PubMed ID: 17537200
[No Abstract] [Full Text] [Related]
7. A presumably benign human ether-a-go-go-related gene mutation (R176W) with a malignant primary manifestation of long QT syndrome.
Donner BC; Marschall C; Schmidt KG
Cardiol Young; 2012 Jun; 22(3):360-3. PubMed ID: 22067087
[TBL] [Abstract][Full Text] [Related]
8. Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome.
Itoh H; Sakaguchi T; Ding WG; Watanabe E; Watanabe I; Nishio Y; Makiyama T; Ohno S; Akao M; Higashi Y; Zenda N; Kubota T; Mori C; Okajima K; Haruna T; Miyamoto A; Kawamura M; Ishida K; Nagaoka I; Oka Y; Nakazawa Y; Yao T; Jo H; Sugimoto Y; Ashihara T; Hayashi H; Ito M; Imoto K; Matsuura H; Horie M
Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):511-23. PubMed ID: 19843919
[TBL] [Abstract][Full Text] [Related]
9. Atrioventricular block-induced Torsades de Pointes with clinical and molecular backgrounds similar to congenital long QT syndrome.
Oka Y; Itoh H; Ding WG; Shimizu W; Makiyama T; Ohno S; Nishio Y; Sakaguchi T; Miyamoto A; Kawamura M; Matsuura H; Horie M
Circ J; 2010 Nov; 74(12):2562-71. PubMed ID: 20975234
[TBL] [Abstract][Full Text] [Related]
10. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG
Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533
[TBL] [Abstract][Full Text] [Related]
11. Genetics of long QT syndrome.
Tester DJ; Ackerman MJ
Methodist Debakey Cardiovasc J; 2014; 10(1):29-33. PubMed ID: 24932360
[TBL] [Abstract][Full Text] [Related]
12. Functional assessment of compound mutations in the KCNQ1 and KCNH2 genes associated with long QT syndrome.
Grunnet M; Behr ER; Calloe K; Hofman-Bang J; Till J; Christiansen M; McKenna WJ; Olesen SP; Schmitt N
Heart Rhythm; 2005 Nov; 2(11):1238-49. PubMed ID: 16253915
[TBL] [Abstract][Full Text] [Related]
13. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
Vincent GM
Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
[TBL] [Abstract][Full Text] [Related]
14. Peripartum cardiomyopathy presenting with syncope due to Torsades de pointes: a case of long QT syndrome with a novel KCNH2 mutation.
Nishimoto O; Matsuda M; Nakamoto K; Nishiyama H; Kuraoka K; Taniyama K; Tamura R; Shimizu W; Kawamoto T
Intern Med; 2012; 51(5):461-4. PubMed ID: 22382559
[TBL] [Abstract][Full Text] [Related]
15. Acute respiratory distress syndrome with transiently impaired left ventricular function and Torsades de Pointes arrhythmia unmasking congenital long QT syndrome in a 25-yr-old woman.
Hinterseer M; Irlbeck M; Ney L; Beckmann BM; Pfeufer A; Steinbeck G; Kaab S
Br J Anaesth; 2006 Aug; 97(2):150-3. PubMed ID: 16720674
[TBL] [Abstract][Full Text] [Related]
16. Genetics of acquired long QT syndrome.
Roden DM; Viswanathan PC
J Clin Invest; 2005 Aug; 115(8):2025-32. PubMed ID: 16075043
[TBL] [Abstract][Full Text] [Related]
17. QT interval prolongation and cardiac risk assessment for novel drugs.
Picard S; Lacroix P
Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
[TBL] [Abstract][Full Text] [Related]
18. Takotsubo cardiomyopathy and congenital long QT syndrome in a patient with a novel duplication in the Per-Arnt-Sim (PAS) domain of hERG1.
Grilo LS; Pruvot E; Grobéty M; Castella V; Fellmann F; Abriel H
Heart Rhythm; 2010; 7(2):260-5. PubMed ID: 20004623
[No Abstract] [Full Text] [Related]
19. Counting mRNA in blood of LQTS - new direction?
Zaręba W
Kardiol Pol; 2011; 69(5):430. PubMed ID: 21594823
[No Abstract] [Full Text] [Related]
20. hERG: protein trafficking and potential for therapy and drug side effects.
Staudacher I; Schweizer PA; Katus HA; Thomas D
Curr Opin Drug Discov Devel; 2010 Jan; 13(1):23-30. PubMed ID: 20047143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
